Skip to main content
SpringerLink
Log in

Renale Manifestationen rheumatischer Erkrankungen

Renal manifestations of rheumatic diseases

Zeitschrift für Rheumatologie volume 64, pages 18–25 (2005)Cite this article

Zusammenfassung

Entzündlich-rheumatische Erkrankungen weisen im Verlauf nicht selten subklinische oder auch klinisch relevante Nierenmanifestationen auf. Dies gilt im Besonderen für die Systemerkrankungen, also Kollagenosen und Vaskulitiden, bei denen ein renaler Befall Prognose- und Therapie-entscheidend sein kann. Weniger bekannt sind die häufig schleichend verlaufenden renalen Beteiligungen der rheumatoiden Arthritis und der Spondyloarthritiden. Langjährig entzündlich aktive rheumatische Erkrankungen können zudem durch sekundäre AA-Amyloidosen mit renaler Manifestation kompliziert werden. Klinisch gilt es, die glomerulären (nephritisches und nephrotisches Syndrom, rapid-progrediente Nephritis) von den tubulo-interstitiellen Syndromen zu unterscheiden. Im Einzelfall stellt sich bei Nierenfunktionsstörungen die Differentialdiagnose zu Rheuma-unabhängigen Nierenerkrankungen, zu Infektionen und zu medikamentös bedingten glomerulären und tubulo-interstitiellen Nierenschäden.

Summary

Inflammatory rheumatic diseases are frequently complicated by subclinical or overt renal manifestations. This is well known for the connective tissue diseases and vasculitides in which renal disease can be of significant prognostic value and therapeutic implication. However, rheumatoid arthritis and the spondyloarthritides can also be associated with direct renal manifestation or with secondary renal AA-amyloidosis. The clinician should be aware of the different glomerular (i. e. nephritic or nephritic syndrome, rapidly progressive renal disease) and tubulo-interstitial syndromes. In any case of renal dysfunction in a rheumatic patient, the differential diagnosis should include renal disease independent from the rheumatic condition, infection, and drug-induced renal toxicity.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Alenius GM, Stegmayr BG, Dahlqvist SR (2001) Renal abnormalities in a population of patients with psoriatic arthritis. Scand J Rheumatol 30:271–274

    Google Scholar 

  2. Bansal VK, Beto JA (1997) Treatment of lupus nephritis: a meta-analysis of clinical trials. Am J Kid Dis 29:193–199

    Google Scholar 

  3. Beddhu S, Bastacky S, Johnson JP (2002) The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 81:398–409

    Google Scholar 

  4. Booth AD, Pusey CD, Jayne DR (2004) Renal vasculitis—an update in 2004. Nephrol Dial Transplant 19:1964–1968

    Article  Google Scholar 

  5. Bossini N, Savoldi S, Franceschini F, Mombelloni S, Baronio M, Cavazzana I, Viola BF, Valzorio B, Mazzucchelli C, Cattaneo R, Scolari F, Maiorca R (2001) Clinical and morphological features of kidney involvement in primary Sjogren’s syndrome. Nephrol Dial Transplant 16:2328–2336

    Google Scholar 

  6. Cameron JS (1999) Lupus nephritis. J Am Soc Nephrol 10:413–424

    CAS  PubMed  Google Scholar 

  7. Clements PJ, Lachenbruch PA, Furst DE, Maxwell M, Danovitch G, Paulus HE (1994) Abnormalities of renal physiology in systemic sclerosis. A prospective study with 10-year followup. Arthritis Rheum. 37:67–74

    Google Scholar 

  8. Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O’Nan P, Roth D (2004) Sequential therapies for proliferative lupus nephritis. N Engl J Med 350:971–980

    Article  CAS  PubMed  Google Scholar 

  9. D’Amico G, Colasanti G, Ferrario F, Sinico RA (1989) Renal involvement in essential mixed cryoglobulinemia. Kidney Int 35:1004–1014

    Google Scholar 

  10. Denton CP, Sweny P, Abdulla A, Black CM (1994) Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases. Br J Rheumatol 33:90–92

    Google Scholar 

  11. Donadio JV Jr, Burgess JH, Holley KE (1977) Membranous lupus nephropathy: a clinicopathologic study. Medicine (Baltimore) 56:527–536

    Google Scholar 

  12. Exley AR, Bacon PA, Luqmani RA, Kitas GD, Carruthers DM, Moots R (1998) Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). Br J Rheumatol 37:57–63

    Google Scholar 

  13. Fabrizi F, Colucci P, Ponticelli C, Locatelli F (2002) Kidney and liver involvement in cryoglobulinemia. Semin Nephrol 22:309–318

    Google Scholar 

  14. Fiehn C, Andrassy K (2004) Case number 29: hitting three with one strike: rapid improvement of psoriatic arthritis, psoriatic erythroderma, and secondary renal amyloidosis by treatment with infliximab (Remicade). Ann Rheum Dis 63:232

    Google Scholar 

  15. Gelbart DR, Weinstein AB, Fajardo LF (1977) Allopurinol-induced interstitial nephritis. Ann Intern Med 86:196–198

    Google Scholar 

  16. Glassock RJ (2004) Reclassification of lupus glomerulonephritis: Back to the future. J Am Soc Nephrol 15:501–503

    Google Scholar 

  17. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC (1980) Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69:287–308

    Article  CAS  PubMed  Google Scholar 

  18. Goules A, Masouridi S, Tzioufas AG, Ioannidis JP, Skopouli FN, Moutsopoulos HM (2000) Clinically significant and biopsy-documented renal involvement in primary Sjogren’s syndrome. Medicine (Baltimore) 79:241–249

    Google Scholar 

  19. Hart TC, Gorry MC, Hart PS, Woodard AS, Shihabi Z, Sandhu J, Shirts B, Xu L, Zhu H, Barmada MM, Bleyer AJ (2002) Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 39:882–892

    CAS  PubMed  Google Scholar 

  20. Hauer HA, Bajema IM, Van Houwelingen HC Ferrario F, Noel LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC; European Vasculitis Study Group (EUVAS) (2002) Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 62:1732–1742

    Google Scholar 

  21. Helfrich DJ, Banner B, Steen VD, Medsger TA Jr (1989) Normotensive renal failure in systemic sclerosis. Arthritis Rheum 32:1128–1134

    Google Scholar 

  22. Helin HJ, Korpela MM, Mustonen JT, Pasternack AI (1995) Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 38:242–247

    Google Scholar 

  23. Hermann E, Mayet W-J, Wandel E, Scherer G, Schadmand S, Klose KJ, Poralla T, Meyer zum Büschenfelde K-H, Köhler H (1991) Rheumatologische und radiologische Symptome der Dialyse-assoziierten 2-Mikroglobulin-Amyloidose: Retrospektive Langzeituntersuchung an 175 chronischen Hämodialysepatienten. Z Rheumatol 50:160–167

    Google Scholar 

  24. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498

    PubMed  Google Scholar 

  25. Houssiau FA, Vasconcelos C, D’Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gul A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R (2002) Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46:2121–2131

    Article  CAS  PubMed  Google Scholar 

  26. Huynh-Do U (2004) Gout nephropathy—ghost or reality? Ther Umsch 61:567–569

    Google Scholar 

  27. Köhler H, Wandel E, Brunck B (1991) Acanthocyturia—a characteristic marker for glomerular bleeding. Kidney Internat 40:115–120

    Google Scholar 

  28. Kohno K, Katayama T, Majima K, Fujisawa M, Iida S, Fukami K, Ueda S, Nishida H, Sata M, Kato S, Morimatsu M, Okuda S (2000) A case of normotensive scleroderma renal crisis after high-dose methylprednisolone treatment. Clin Nephrol 53:479–482

    Google Scholar 

  29. Korpela M, Mustonen J, Teppo AM, Helin H, Pasternack A (1997) Mesangial glomerulonephritis as an extraarticular manifestation of rheumatoid arthritis. Br J Rheumatol 36:1189–1195

    Google Scholar 

  30. Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC (2003) The association between gout and nephrolithiasis in men: The Health Professionals’ Follow-Up Study. Kidney Int 64:1022–1026

    Google Scholar 

  31. Livi R, Teghini L, Pignone A, Generini S, Matucci-Cerinic M, Cagnoni M (2002) Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement. Ann Rheum Dis 61:682–686

    Google Scholar 

  32. Lopez-Ovejero JA, Saal SD, D’Angelo WA, Cheigh JS, Stenzel KH, Laragh JH (1979) Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med 300:1417–1419

    Google Scholar 

  33. Medsger, TA Jr, Masi, AT, Rodnan, GP, Benedek TG, Robinson H (1971) Survival with systemic sclerosis (scleroderma). Ann Intern Med 75:369–376

    Google Scholar 

  34. Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardieri S, Bordin G et al (1995) Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary. QJM 88:115–126

    Google Scholar 

  35. Montenegro V, Monteiro RC (1999) Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role. Curr Opin Rheumatol 11:265–272

    Google Scholar 

  36. Mustila A, Korpela M, Mustonen J, Helin H, Huhtala H, Soppi E, Pasternack A, Miettinen A (1997) Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy. Arthritis Rheum 40:710–717

    CAS  PubMed  Google Scholar 

  37. Nossent HC, Henzen-Logmans SC, Vroom TM, Berden JH, Swaak TJ (1990) Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum, 33:970–977

    Google Scholar 

  38. Park MH, D’Agati V, Appel GB, Pirani CL (1986) Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 44:309–319

    CAS  PubMed  Google Scholar 

  39. Satko SG, Iskandar SS, Appel RG (2000) IgA nephropathy and Reiter’s syndrome. Report of two cases and review of the literature. Nephron 84:177–182

    Google Scholar 

  40. Schiff MH, Whelton A (2000) Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis. Semin Arthritis Rheum 30:196–208

    Google Scholar 

  41. Schreiner O, Wandel E, Himmelsbach F, Galle PR, Märker-Hermann E (2000) Reduced secretion of proinflammatory cytokines of monosodium urate crystal-stimulated monocytes in chronic renal failure: an explanation for infrequent gout episodes in chronic renal failure patients? Nephrol Dial Transplant 15:644–649

    Google Scholar 

  42. Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ (1993) Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 21:374–377

    Google Scholar 

  43. Steen VD, Medsger TA Jr, Osial TA Jr et al (1984) Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 76:779–786

    Google Scholar 

  44. Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613–1619

    Google Scholar 

  45. Steen VD and Medsger TA Jr (2000) Long-term outcomes of scleroderma renal crisis. Ann Intern Med 133:600–603

    Google Scholar 

  46. Strobel ES, Fritschka E (1998) Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports. Clin Rheumatol 17:524–530

    Google Scholar 

  47. Tam FW, Sanders JS, George A, Hammad T, Miller C, Dougan T, Cook HT, Kallenberg CG, Gaskin G, Levy JB, Pusey CD (2004) Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant 19:2761–2768

    Google Scholar 

  48. Traub YM, Shapiro AP, Rodnan GP, Medsger TA, McDonald RH Jr, Steen VD, Osial TA Jr, Tolchin SF (1983) Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore) 62:335–352

    Google Scholar 

  49. Vilar MJ, Cury SE, Ferraz MB, Sesso R, Atra E (1997) Renal abnormalities in ankylosing spondylitis. Scand J Rheumatol 26:19–23

    Google Scholar 

  50. Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M; International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530

    Google Scholar 

  51. Westman KW, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, Wieslander J (1998) Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Kidney Int 53:1230–1236

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I. Medizinische Klinik und Poliklinik der Johannes-Gutenberg-Universität, 55101, Mainz, Germany

    A. Schwarting

  2. Klinik Innere Medizin IV, HSK Dr.-Horst-Schmidt-Kliniken GmbH, Aukammallee 39, 65191, Wiesbaden, Germany

    E. Märker-Hermann

Authors
  1. A. Schwarting
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Märker-Hermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Schwarting.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Schwarting, A., Märker-Hermann, E. Renale Manifestationen rheumatischer Erkrankungen. Z. Rheumatol. 64, 18–25 (2005). https://doi.org/10.1007/s00393-005-0700-1

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-005-0700-1

Schlüsselwörter

Key words

search

Navigation